Nivata IPO Market Data
Green Asia Impex
IPO GMP & Details
Check Green Asia Impex IPO GMP and its recorded history, price band, issue dates, total subscription, lot size and listing date. Unofficial GMP is not a listing forecast.
At a glance
Green Asia Impex IPO details
Unofficial market context
Green Asia Impex IPO GMP trend
The chart shows recent GMP movement over time. GMP is unofficial and should not be treated as a listing-price forecast or recommendation.
Latest chart observation₹0
Change across recorded history₹0
Recorded observations2
Current GMP reference price₹89
₹0₹0
1 Oct2 Oct
| Observation | GMP | Change | Reference price |
|---|---|---|---|
| 2 Oct 2026, 5:25 AM | ₹0 | ₹0 | ₹89 |
| 1 Oct 2026, 2:32 PM | ₹0 | — | ₹89 |
Issue schedule & market details
Green Asia Impex IPO key data
These are structured market-data fields. Missing values are left blank rather than estimated.
Issue typeSME
ExchangeNSE SME
Price band₹84 – ₹89
Issue price₹89
Lot size1,600 shares
Issue size₹60.1 Cr
Open date24 Sep 2026
Close date1 Oct 2026
Listing date7 Oct 2026
Overall subscription0× subscribed
Last recorded GMP₹0
GMP reference price₹89
Quick facts
Green Asia Impex IPO FAQs
When does the Green Asia Impex IPO open and close?
The opening date is 24 Sep 2026. The closing date is 1 Oct 2026.
When is the Green Asia Impex IPO listing date?
The currently recorded listing date is 7 Oct 2026. The timetable can change if the issue schedule is revised.
What is the Green Asia Impex IPO price band?
The currently recorded price band is ₹84 – ₹89.
What is the Green Asia Impex IPO GMP?
The latest GMP recorded by Nivata is ₹0. GMP is unofficial market information and is not a listing-price forecast.
What is the Green Asia Impex IPO lot size?
The recorded lot size is 1,600 shares. Review the official issue terms before applying.
What is the Green Asia Impex IPO subscription?
Nivata currently records overall issue subscription at 0 times. This is not an allotment probability.
This page contains factual IPO schedule, pricing, subscription, listing and GMP information. It does not contain an IPO research article and does not provide a recommendation, rating, target price, valuation conclusion, expected return, listing forecast, allotment probability or a view on whether to participate in the issue.